Tech Company Financing Transactions
Valo Health Funding Round
Valo Health closed a $190 million Series B funding round on 1/19/2021. Investors included Flagship Pioneering, PSP Investments and Atinum Investment.
Transaction Overview
Company Name
Announced On
1/19/2021
Transaction Type
Venture Equity
Amount
$190,000,000
Round
Series B
Investors
Flagship Pioneering (Lead Investor)
PSP Investments (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
399 Boylston St. 505
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Undisclosed
Website
Email Address
Overview
Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reduce cost, time, and failure rate.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Berry
Chief Financial Officer
Graeme Bell
Chief Operating Officer
Hilary Malone
Chief Technical Officer
Brett Blackman
VP - Bus. Development
Moni Miyashita
VP - Bus. Development
Daniel Troy
VP - Human Resources
Cissy Young
Browse more venture capital transactions:
Prev: 1/19/2021: The Blinc Group venture capital transaction
Next: 1/19/2021: Sustainment venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs